These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effects of fall-risk-increasing drugs on postural control: a literature review. de Groot MH; van Campen JP; Moek MA; Tulner LR; Beijnen JH; Lamoth CJ Drugs Aging; 2013 Nov; 30(11):901-20. PubMed ID: 24005984 [TBL] [Abstract][Full Text] [Related]
3. Cognitive effects of antiepileptic drugs. Park SP; Kwon SH J Clin Neurol; 2008 Sep; 4(3):99-106. PubMed ID: 19513311 [TBL] [Abstract][Full Text] [Related]
4. Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. Mathew SJ; Murrough JW; aan het Rot M; Collins KA; Reich DL; Charney DS Int J Neuropsychopharmacol; 2010 Feb; 13(1):71-82. PubMed ID: 19288975 [TBL] [Abstract][Full Text] [Related]
5. Pharmacological treatment effects on eye movement control. Reilly JL; Lencer R; Bishop JR; Keedy S; Sweeney JA Brain Cogn; 2008 Dec; 68(3):415-35. PubMed ID: 19028266 [TBL] [Abstract][Full Text] [Related]
7. Lamotrigine. A review of its use in childhood epilepsy. Culy CR; Goa KL Paediatr Drugs; 2000; 2(4):299-330. PubMed ID: 10946418 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug concentration monitoring using saliva samples. Focus on anticonvulsants. Liu H; Delgado MR Clin Pharmacokinet; 1999 Jun; 36(6):453-70. PubMed ID: 10427469 [TBL] [Abstract][Full Text] [Related]
9. Lamotrigine. An update of its pharmacology and therapeutic use in epilepsy. Fitton A; Goa KL Drugs; 1995 Oct; 50(4):691-713. PubMed ID: 8536554 [TBL] [Abstract][Full Text] [Related]
10. Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. Goa KL; Ross SR; Chrisp P Drugs; 1993 Jul; 46(1):152-76. PubMed ID: 7691504 [TBL] [Abstract][Full Text] [Related]
11. Effects of short-term lamotrigine treatment on pharmacokinetics of carbamazepine. Malminiemi K; Keränen T; Kerttula T; Moilanen E; Ylitalo P Int J Clin Pharmacol Ther; 2000 Nov; 38(11):540-5. PubMed ID: 11097146 [TBL] [Abstract][Full Text] [Related]
12. Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Cohen AF; Ashby L; Crowley D; Land G; Peck AW; Miller AA Br J Clin Pharmacol; 1985 Dec; 20(6):619-29. PubMed ID: 4091994 [TBL] [Abstract][Full Text] [Related]
13. Lamotrigine: a review of antiepileptic efficacy. Yuen AW Epilepsia; 1994; 35 Suppl 5():S33-6. PubMed ID: 8039468 [TBL] [Abstract][Full Text] [Related]
14. Carbamazepine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosage. Hamilton MJ; Cohen AF; Yuen AW; Harkin N; Land G; Weatherley BC; Peck AW Epilepsia; 1993; 34(1):166-73. PubMed ID: 8422853 [TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacology of lamotrigine. Peck AW Epilepsia; 1991; 32 Suppl 2():S9-12. PubMed ID: 1773780 [TBL] [Abstract][Full Text] [Related]
16. Gabapentin and carbamazepine affect eye movements and posture control differently: a placebo-controlled investigation of acute CNS side effects in healthy volunteers. Noachtar S; von Maydell B; Fuhry L; Büttner U Epilepsy Res; 1998 Jun; 31(1):47-57. PubMed ID: 9696300 [TBL] [Abstract][Full Text] [Related]